recall
saveQuVa Pharma, Inc. recall (Cls II)
community read0 votes
fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.1% Bupivacaine HCl 100 mg/100 mL (1 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75 — Reason: Lack of Assurance of Sterility — Status: Ongoing
view source ↗Data sources
last refreshed 6m ago
Found something off?
same company · ±60 days · 6
- recallQuVa Pharma, Inc. recall (Cls II)Apr 2, 2025
- recallQuVa Pharma, Inc. recall (Cls II)Apr 2, 2025
- approvalacetaminophen ER: HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalApr 3, 2025
- approvalACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE (ACETAMINOPHEN) — FDA approvalApr 14, 2025
- approvalHYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approvalMar 13, 2025
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalFeb 21, 2025
comments(0)
5-min edit window · permanent after that